Trademark applications and grants for Alexion Pharmaceuticals Inc. Alexion Pharmaceuticals Inc has 81 trademark applications. The latest application filed is for "KLYGEFA"
Patent Application | Date |
---|---|
USE OF ANTI-FCRN ANTIBODIES IN THE TREATMENT OF PEMPHIGHUS AND PEMPHIGOID DISEASES 20220298241 - 17/611656 Blumberg; Laurence J. ;   et al. | 2022-09-22 |
ALKALINE PHOSPHATASE POLYPEPTIDES AND METHODS OF USE THEREOF 20220265784 - 17/669275 VOEGTLI; Walter C. ;   et al. | 2022-08-25 |
METHODS FOR TREATMENT OF REFRACTORY GENERALIZED MYASTHENIA GRAVIS WITH ECULIZUMAB 20220259305 - 17/630601 Wang; Jing Jing ;   et al. | 2022-08-18 |
COMPOSITIONS AND METHODS FOR PREPARING FACTOR XA AND DERIVATIVES 20220251534 - 17/629999 Lu; Genmin | 2022-08-11 |
DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) 20220235121 - 17/424794 Payton; Lori ;   et al. | 2022-07-28 |
NCAGE Code | 4EXK1 | ALEXION PHARMACEUTICALS, INC. |
CAGE Code | 4EXK1 | ALEXION PHARMACEUTICALS, INC. |
S.A.M. Registration | 4EXK1 [789359510] | ALEXION PHARMACEUTICALS, INC. |
SEC | 0000899866 | ALEXION PHARMACEUTICALS, INC. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.